The Wegovy Pill: Everything You Need to Know About Oral Semaglutide for Weight Loss

What is the Wegovy Pill?

The Wegovy Pill is an oral tablet form of semaglutide — the same GLP-1 receptor agonist that's helped millions lose weight through Wegovy injections. Manufactured by Novo Nordisk and MHRA-approved in 2026, it's the first oral semaglutide specifically licensed for weight management in the UK.

If you've been interested in semaglutide but put off by weekly injections, this is genuinely significant. You take a small tablet once a day instead. Same active ingredient, same mechanism of action — just a different delivery route.

It's worth noting that oral semaglutide isn't entirely new. Rybelsus (oral semaglutide at lower doses) has been prescribed for type 2 diabetes for several years. But the Wegovy Pill delivers semaglutide at the higher doses needed for meaningful weight loss — up to 25mg daily — which is a substantial step forward.

How SNAC technology makes it possible

Peptide medications like semaglutide are proteins — and your stomach is specifically designed to break proteins down. That's why most biological drugs have historically required injection: if you swallowed them, your digestive system would destroy them before they could work.

The Wegovy Pill solves this with a compound called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate). SNAC is a permeation enhancer that does two things:

• Protects semaglutide — it creates a localised buffer around the tablet, raising the pH in your stomach to shield the peptide from acidic breakdown
• Enhances absorption — SNAC promotes the transcellular transport of semaglutide across the gastric epithelium, allowing it to enter the bloodstream directly through the stomach lining

This is why the dosing instructions matter so much. The pill needs to be taken on a completely empty stomach with a small amount of plain water — no food, other drinks, or medications for 30 minutes afterwards. Food in the stomach interferes with the SNAC mechanism and dramatically reduces absorption.

It's an elegant piece of pharmaceutical engineering, and it's what makes the difference between the tiny Rybelsus doses (up to 14mg) and the weight-loss-effective doses in the Wegovy Pill (up to 25mg).

Clinical trial results (OASIS 1 & OASIS 4)

The landmark trial for the Wegovy Pill is OASIS 1 — a phase 3, randomised, double-blind, placebo-controlled study involving 667 participants with obesity or overweight with at least one weight-related comorbidity.

The headline results were impressive:

To put that in context: a 16.6% average weight loss is clinically very significant. For someone weighing 100kg, that's roughly 16.6kg — over two and a half stone. While it's slightly lower than the ~15–17% seen with injectable Wegovy in the STEP trials, the results are in the same ballpark, which is remarkable for an oral medication.

Participants in the placebo group lost just 1.9% of their body weight over the same period, confirming that the effects are medication-driven rather than lifestyle-driven.

OASIS 4: longer-term confirmation

The OASIS 4 trial provides further long-term evidence, following participants over 71 weeks:

OASIS 4 also showed meaningful improvements in waist circumference, blood sugar levels, and cardiovascular risk markers — benefits that go well beyond the number on the scales. The finding that roughly one in four participants achieved 20% or greater weight loss is particularly notable for an oral medication.

The MHRA approved the Wegovy Pill on 11 June 2026, making the UK the first country in Europe to approve oral semaglutide for weight management. It became available at our clinic from 1 July 2026.

Dosing schedule and how to take it

Like all GLP-1 medications, the Wegovy Pill follows a dose escalation protocol. You start low and build up gradually to give your body time to adjust and minimise side effects.

The dose escalation typically takes around 16 weeks before reaching the full maintenance dose. Your prescriber may adjust the schedule based on how you respond and any side effects you experience.

How to take the Wegovy Pill

Getting this right is important — it directly affects how well the medication absorbs:

1. Take it first thing in the morning on a completely empty stomach — at least 6 hours after your last food or drink
2. Swallow the tablet whole with up to 120ml (half a glass) of plain water. Do not crush, chew, or split it
3. Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medications
4. Take it at roughly the same time each day to maintain consistent blood levels

Practical tips for daily use

Taking a daily tablet sounds simple, but there are a few practical things that can make a real difference to your experience and results:

One last practical point: side effects — particularly nausea — may be more noticeable when you start a new dose. This is normal and usually settles within a week or two. The full therapeutic effect is typically seen at the 25mg maintenance dose.

Pill vs injection: how they compare

This is the question we get asked most. Both forms contain semaglutide and work through the same GLP-1 receptor mechanism. But there are meaningful practical differences:

Neither option is objectively "better" — it depends on your lifestyle and preferences. If you dislike needles, travel frequently, or want something that doesn't need refrigeration, the pill may suit you well. If you'd rather take something once a week and not worry about morning fasting, the injection might be more convenient.

From a clinical effectiveness standpoint, both deliver comparable results. The OASIS 1 data for the pill (16.6%) is broadly in line with the STEP trial data for the injection. We're happy to discuss which option works best for you during your consultation.

Side effects and safety

Because the Wegovy Pill contains the same active ingredient as injectable semaglutide, the side effect profile is very similar. The most common side effects are gastrointestinal:

Most side effects are mild to moderate and tend to improve as your body adjusts, particularly during the dose escalation phase. This is one of the reasons we increase the dose gradually — it gives your system time to adapt.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and (in very rare cases) thyroid tumours. We screen for risk factors before prescribing and monitor throughout treatment. If you experience severe or persistent symptoms, contact us or seek medical attention.

Who is the Wegovy Pill for?

The eligibility criteria are the same as for injectable Wegovy. You may be a candidate if you:

• Have a BMI of 30 or above (obesity)
• Have a BMI of 27 or above with at least one weight-related health condition (e.g. type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea)
• Are aged 18 or over
• Are not pregnant or breastfeeding

The pill may be particularly appealing if you:

• Have a needle phobia or strong dislike of injections
• Travel frequently and want to avoid carrying injectable medications through airports
• Prefer not to deal with refrigeration requirements
• Want a lower-cost entry point (starting from £99/month compared to £199 for injections)
• Simply prefer taking a daily tablet to a weekly injection

Pricing and availability at TLWLC

The Wegovy Pill is available now at The London Weight Loss Clinic. Our pricing is transparent and includes your medication, prescription, and clinical support:

To get started, you'll need to complete our online health assessment. Our clinical team will review your health profile, confirm eligibility, and — if appropriate — issue your prescription, typically within 24 hours.

Frequently asked questions